Treatments for Iron Deficiency (ID): Prospective Organic Iron Fortification

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F62690094%3A18470%2F19%3A50015634" target="_blank" >RIV/62690094:18470/19:50015634 - isvavai.cz</a>

Result on the web

<a href="http://www.eurekaselect.com/170822/article" target="_blank" >http://www.eurekaselect.com/170822/article</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.2174/1381612825666190319111437" target="_blank" >10.2174/1381612825666190319111437</a>

Result language

angličtina

Original language name

Treatments for Iron Deficiency (ID): Prospective Organic Iron Fortification

Original language description

Iron deficiency, one of the most common nutritional deficient disorders, frequently affects infants, adolescents and pregnant women and impairs growth, development and immune responses. Iron deficiency may also be secondary to gastrointestinal conditions such as gastrectomy and inflammatory bowel disease, as well as cancer and chronic uremia. Iron supplementation is the most commonly selected treatment option for iron deficiency. This review summarizes the iron compounds currently recommended for the iron fortification of foods and for clinical use. Additionally, this review discusses and compares the important aspects of high-quality iron compounds/products and classes of compounds that enhance iron bioavailability. The development of efficient iron fortification methods remains the most cost-effective and long-term approach to the treatment of iron deficiency or related anemia. To date, no orally administered options for iron fortification can sufficiently replace the parenteral administration of iron supplements, which includes the intramuscular injection of iron-dextran to neo-natal piglets and intravenous injection of iron supplements to patients with gastrointestinal disorders. Iron bioavailability may be enhanced by encouraging customers to ingest iron-enriched foods together with dietary sources of vitamin C, folic acid and/or oligosaccharides.

Czech name

—

Czech description

—

Type

J_imp - Article in a specialist periodical, which is included in the Web of Science database

CEP classification

—

OECD FORD branch

30104 - Pharmacology and pharmacy

Project

—

Continuities

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2019

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

CURRENT PHARMACEUTICAL DESIGN

ISSN

1381-6128

e-ISSN

—

Volume of the periodical

25

Issue of the periodical within the volume

3

Country of publishing house

AE - UNITED ARAB EMIRATES

Number of pages

8

Pages from-to

325-332

UT code for WoS article

000469504100010

EID of the result in the Scopus database

—